Form 4 for GILD Gilead Sciences
Accepted 2023-03-14 00:00:00 ET · period of report 2023-03-13 · accession 0001127602-23-010126 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-14 | 2023-03-13 | GILD | Parsey Merdad | Chief Medical Off | S - Sale | $78.99 | -6,126 | 70.1K | -8% | -$483.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-13 | S | D | 6,126 | $78.99 | 70,130 | D | — | — |